Search clinical trials for: Azelastine, Fluticasone

Total 718 results

Amsterdam UMC, location VUmc
GlaxoSmithKline; The Netherlands Cancer Institute

Completed

Randomized Trial of Fluticasone in Bronchial Premalignancy

Bronchogenic Carcinoma

Netherlands
Susanna Naggie, MD
Vanderbilt University Medical Center; National Center for Advancing Translational...

Completed

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)

Covid19

United States
Elena Rubio Gomis
Instituto de Salud Carlos III; Fundacion Investigación Hospital General Universitario...

Terminated

Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children

Dermatitis, Atopic

Spain
GlaxoSmithKline

Completed

A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Seasonal

Austria
Alcon Research

Completed

Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis

Allergic Rhinitis

United States
Hamilton Health Sciences Corporation
AstraZeneca

Completed

Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?

Mild Intermittent Asthma

Canada
GlaxoSmithKline

Completed

A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma

Asthma

United States, Russian Federation, Canada, Germany, Peru, Australia, Mexico, Chile, Costa Rica, Spain, Poland, Lithuania, Latvia
GlaxoSmithKline

Completed

Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.

Asthma

United Kingdom
GlaxoSmithKline

Completed

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Asthma

United Kingdom, New Zealand
Research in Real-Life Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management (QvarAsthma)

Asthma

United Kingdom
GlaxoSmithKline

Completed

Chronic Obstructive Pulmonary Disease Endpoints Study

Pulmonary Disease, Chronic Obstructive

Russian Federation, United States, Estonia, Chile
GlaxoSmithKline

Completed

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

Rhinitis, Allergic, Seasonal

United States
Nicox Ophthalmics, Inc.

Completed

Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis

Blepharitis

United States
NYU Langone Health

Completed

Biomarkers of Irritant-Induced and Allergic Asthma

Asthma

United States
GlaxoSmithKline

Completed

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Japan, Poland, Romania, Russian Federation, Ukraine, Taiwan, Bulgaria, South Africa, Korea, Republic of
Johns Hopkins University
GlaxoSmithKline

Terminated

Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease

Patients With Nasal Polyps
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo

Patients With Active Non-segmental Vitiligo. | Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05% | Cream Compared to NB-UVB Alone in Patients With Non-segmental Vitiligo

Netherlands
GlaxoSmithKline

Completed

Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination

Pulmonary Disease, Chronic Obstructive

Australia
GlaxoSmithKline

Completed

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Asthma

United States, Russian Federation, Peru, Mexico
GlaxoSmithKline

Completed

To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

Asthma

Australia
GlaxoSmithKline

Completed

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Asthma

United States, Argentina, Germany, Japan, Chile, Peru, Philippines, Poland, Mexico, Slovakia, Ukraine, South Africa, Puerto Rico, Georgia
Optinose US Inc.

Completed

12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device

Nasal Polyps

United States
GlaxoSmithKline

Completed

Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

Allergic Rhinitis | Seasonal Allergic Rhinitis

United States
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD

Chronic Obstructive Pulmonary Disease | COPD
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) (BADGER)

Asthma

United States
Research in Real-Life Ltd
Mundipharma Research Limited

Completed

Real-world Effectiveness of Combination Therapy in Asthma

Asthma

United Kingdom
University of Medicine and Pharmacy at Ho Chi Minh...

Recruiting

FLuticasone in cOvid Treatment (FLOT) (FLOT)

Covid19

Vietnam
Boehringer Ingelheim

Terminated

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy

Asthma

United States
Regeneron Pharmaceuticals
Sanofi

Completed

Study of REGN3500 and Dupilumab in Patients With Asthma

Asthma, Allergic

United Kingdom, United States
GlaxoSmithKline

Completed

A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD

Pulmonary Disease, Chronic Obstructive

United States, Germany, Philippines, Thailand, Korea, Republic of, Norway
Ramathibodi Hospital

Completed

Nebulized Corticosteroid for Post Extubation Stridor in Children

Stridor

Thailand
GlaxoSmithKline

Completed

A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD

Pulmonary Disease, Chronic Obstructive

Taiwan, China, Philippines, Korea, Republic of
GlaxoSmithKline

Completed

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

Bronchospasm | Activity/Exercise Induced Bronchospasm

United States
GlaxoSmithKline

Completed

Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids

Asthma

Russian Federation, Belgium, Poland, Spain, Denmark, Italy, Sweden, Netherlands, France, Lithuania, Latvia, Norway
GlaxoSmithKline

Terminated

Study Of RV-39 In Patients Who Also Have Asthma

Asthma

United States
University of Dundee
NHS Tayside; Chief Scientist Office of the Scottish Government

Completed

Medical Polypectomy and Predictors of Response

Nasal Polyps

United Kingdom
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin

United States, Denmark, Italy, France, Australia, United Kingdom
Northwestern University
Genzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.

Completed

Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome

Lymphoma

United States
Merck Sharp & Dohme LLC

Completed

Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis

Allergic Rhinitis
University Hospital, Ghent
MEDA Pharma GmbH & Co. KG; University of Wuerzburg

Withdrawn

Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)

Bioavailability Study

Belgium
University of Dundee

Completed

Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate Asthma

Asthma

United Kingdom
Research Consult GmbH

Completed

Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Seasonal

Austria
GlaxoSmithKline

Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Perennial

China
GlaxoSmithKline

Completed

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

Estonia, United States, Canada, Germany, Slovakia, Russian Federation, Hungary
Boehringer Ingelheim

Terminated

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

Asthma

United States
Boehringer Ingelheim

Terminated

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Asthma

United States
GlaxoSmithKline

Completed

Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Pulmonary Disease, Chronic Obstructive

United States, Germany, Spain, Netherlands, Canada
University of Chicago
GlaxoSmithKline

Completed

Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

Allergic Rhinitis

United States
University of Chicago
GlaxoSmithKline

Completed

Intranasal Steroids and the Nasal Ocular Response

Seasonal Allergic Rhinitis

United States
St. Joseph's Healthcare Hamilton
GlaxoSmithKline

Completed

Relative Potency of Inhaled Corticosteroids

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Canada

3

Subscribe